Moderately hypofractionated and conventionally fractionated radiotherapy demonstrate similar efficacy, but one ...

"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

Outranked only by skin cancer, prostate cancer is the second most common cancer in men in the U.S. Although one in every ...

Recovering erections grabs the attention of most men and their doctors after prostate cancer treatment. A new study redirects ...

Blood tests measure the level of PSA protein, produced by the prostate gland, and may help detect early signs of prostate ...

The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor ...

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.

Kidney stones and gallstones may increase the risk for prostate cancer, which could have implications for disease monitoring and prevention in specific populations. Patients with kidney stones or ...

Real Housewives of Beverly Hills alum Teddi Mellencamp shared her heartbreaking reaction after a fan weighed in on her ...

Kingsley Ekwueme, a professor and pioneering urological and robotic surgeon, is transforming prostate cancer treatment in ...

Physician-scored and patient-reported bowel toxicity higher with dose-escalated moderately hypofractionated radiotherapy.